The South African on MSN
Lenacapavir rollout aims to slash HIV infections in Zimbabwe
The US launches long-acting HIV prevention drug lenacapavir in Zimbabwe, aiming to support thousands of people.
UNAIDS welcomes the results from the HPTN 071 ( PopART ) trial. The results showed a 30% decline in new HIV infections where HIV prevention, including home-based HIV counselling and testing, was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results